MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 2.760
-0.010 (-0.36%)
Jun 23, 2026, 5:35 PM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €52.01 million as of June 23, 2026. Its market cap has decreased by -38.29% in one year.
Market Cap
52.01M
Enterprise Value
44.58M
Revenue
4.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.76
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 52.01M, a decrease of -60.82%. That is a compound annual growth rate of -18.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 52.01M | -32.86% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innate Pharma | 150.88M |
| Sensorion | 132.54M |
| Valerio Therapeutics Société anonyme | 103.39M |
| OSE Immunotherapeutics | 82.13M |
| Adocia | 80.81M |
| ABIONYX Pharma | 77.47M |
| THX Pharma Société Anonyme | 47.46M |
| Fermentalg | 46.21M |